{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:52:56Z","timestamp":1790812376373,"version":"4.1.0"},"reference-count":32,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The synergism of combined use between oral finasteride and topical minoxidil has been established in treating androgenetic alopecia among men. However, the concern regarding adverse effects of finasteride use has been rising.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To compare the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in men with androgenetic alopecia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Forty men aged 18\u201360\u00a0years with androgenetic alopecia were randomized to 24\u00a0weeks of treatment with a finasteride\/minoxidil or minoxidil solution twice daily. Primary efficacy endpoint was the change from baseline in hair density and hair diameter at week 24. Secondary endpoints included global photographic assessment by treatment\u2010blinded investigators and subjects. Changes in plasma dihydrotestosterone levels and adverse events were recorded.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At week 24, the combined solution of finasteride and minoxidil was significantly superior to minoxidil alone in improvements of hair density, hair diameter and global photographic assessment (all <jats:italic>P\u00a0<\/jats:italic>&lt;<jats:italic>\u00a0<\/jats:italic>0.05). About 90% of patients treated with the combined solution experienced moderate to marked improvement. The combined solution also had minimal effect on plasma dihydrotestosterone levels, approximately 5% reduction. There were also no systemic adverse events reported by patients in both groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Treatment with topical solution of 0.25% finasteride admixed with 3% minoxidil was significantly superior to 3% minoxidil solution for promoting hair growth in male androgenetic alopecia, and well tolerated.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.15171","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T20:50:23Z","timestamp":1530737423000},"page":"2257-2263","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["A randomized, double\u2010blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia"],"prefix":"10.1111","volume":"32","author":[{"given":"P.","family":"Suchonwanit","sequence":"first","affiliation":[{"name":"Division of Dermatology Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Srisuwanwattana","sequence":"additional","affiliation":[{"name":"Division of Dermatology Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Chalermroj","sequence":"additional","affiliation":[{"name":"Division of Dermatology Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Khunkhet","sequence":"additional","affiliation":[{"name":"Division of Dermatology Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(02)00372-6"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-38-5-811"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.3.703"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.256"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.813011"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70007-6"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70081-2"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.10.027"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.02.054"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15081"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2002.tb00314.x"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12246"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546639709160517"},{"key":"e_1_2_5_15_1","first-page":"881","article-title":"Randomized double\u2010blind placebo controlled trial in the treatment of male androgenetic alopecia with 0.1% finasteride solution. Jpn","volume":"113","author":"Charuwichitratana S","year":"2003","journal-title":"J Dermatol"},{"key":"e_1_2_5_16_1","volume-title":"Clinical Evaluation of Topical Formulation of Finasteride in Male Androgenetic Alopecia [Dissertation]","author":"Sitticharoenchai P","year":"2006"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.45220"},{"key":"e_1_2_5_18_1","first-page":"253","article-title":"A new topical formulation of minoxidil and finasteride improves hair growth in men with androgenetic alopecia","volume":"6","author":"Saifuddin S","year":"2015","journal-title":"J Clin Exp Dermatol Res"},{"key":"e_1_2_5_19_1","first-page":"1312","article-title":"Efficacy and safety of 3% minoxidil versus combined 3% minoxidil\/0.1% finasteride in male pattern hair loss: a randomized, double\u2010blind, comparative study","volume":"95","author":"Tanglertsampan C","year":"2012","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP202119"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.5414\/CP202467"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.186.4170.1213"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02255.x"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.02157.x"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.3020"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.36"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14223"},{"key":"e_1_2_5_28_1","first-page":"457","article-title":"A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women","volume":"17","author":"Lee SW","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.2174\/187221312800166859"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.1992.tb01621.x"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2015.04.008"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2014.01.003"},{"key":"e_1_2_5_33_1","unstructured":"Stockholm County Council.2014\u20102015 Environmentally classified pharmaceuticals. 2014. URLhttp:\/\/www.janusinfo.se\/Global\/Miljo_och_lakemedel\/Miljobroschyr_2014_engelsk_webb.pdf(last accessed: 28 May 2018)."}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.15171","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.15171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:15:21Z","timestamp":1694751321000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.15171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1111\/jdv.15171"],"URL":"https:\/\/doi.org\/10.1111\/jdv.15171","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"2017-07-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}